Because the gut/brain axis is a major bidirectional pathway used by the body to trigger most chemical signaling needed for activating hormonal release in many metabolic pathways, GLP-1 follows a circadian rhythm with higher levels during the daytime and evening than overnight
Research has shown, for instance, that nearly 1 in 5 UTIs may come from a strain of E
Post-marketing surveillance has also examined potential associations with pancreatic cancer, given the pancreatic effects of these medications, though current evidence does not support a causal relationship
GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications
The focus on preventive care and chronic disease management is another factor that helps North America to be at the forefront of the GLP-1 analogues industry
The most successful strategy for maintaining GLP-1 results involves building the behavioral foundation during treatment